Dl. Lamping et al., Clinical outcomes, quality of life, and costs in the North Thames DialysisStudy of elderly people on dialysis: a prospective cohort study, LANCET, 356(9241), 2000, pp. 1543-1550
Citations number
32
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Background Evidence-based health policy is urgently needed to meet the incr
easing demand for health services among elderly people, particularly for ex
pensive technologies such as renal-replacement therapy. Age has been used t
o ration dialysis, although not always explicitly, despite the lack of rigo
rous empirical evidence about how elderly people fare on dialysis. We under
took a comprehensive assessment of outcomes in patients 70 years or over.
Methods We did a 12-month prospective cohort study of outcomes in 221 patie
nts with end-stage renal failure aged 70 years or over recruited from four
hospital-based renal units, We assessed 1-year survival in 125 incident pat
ients (70-86 years) and disease burden (hospital admissions, quality of lif
e, costs) in 174 prevalent patients (70-93 years).
Findings 1-year survival rates were: 71% overall; 80%, 69%, and 54% in pati
ents 70-74 years, 75-79 years, and 80 years and older, respectively (p=0008
); and 88%, 71%, and 64% in patients with no, one, or two or more comorbid
conditions, respectively (p=0056), Cox regression analyses showed that mort
ality was significantly associated with age 80 years and older (relative ri
sk 2.79 [95% CI 1.28-6.93]) and peripheral vascular disease (2.83 [1.29-6.1
7]), but not with diabetes, ischaemic heart disease, cerebrovascular diseas
e, chronic obstructive airways disease, sex, or treatment method. In terms
of disease burden, hospital admissions represent a low proportion of costs
and was not required by a third of patients, mental quality of life in elde
rly dialysis patients was similar to that of elderly people in the general
population, and the average annual cost per patient of pound 20 802 (US$31
200) (68% dialysis treatment, 1% transport, 19% inpatient hospital admissio
ns, 12% medications) was within the range of other life-extending intervent
ions.
Interpretation Our results suggest that age alone should not be used as a b
arrier to referral and treatment and emphasise the need to consider the ben
efits of dialysis in elderly people. Indicators of the ability to benefit f
rom treatment, rather than chronological age, should be used to develop pol
icies that ensure equal access to care for all.